CA
AMPH icon

Clearstead Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History

Clearstead Advisors’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-108
Closed -$4.01K – 2200
2024
Q4 		$4.01K Hold
108
– – ﹤0.01% 1754
2024
Q3 		$5.24K Hold
108
– – ﹤0.01% 1704
2024
Q2 		$4.32K Buy
108
+8
+8% +$332 ﹤0.01% 1707
2024
Q1 		$4.24K Sell
100
-19
-16% -$981 ﹤0.01% 1199
2023
Q4 		$7.36K Buy
119
+65
+120% +$3.42K ﹤0.01% 1108
2023
Q3 		$2.48K Buy
54
+27
+100% +$1.47K ﹤0.01% 1370
2023
Q2 		$1.55K Sell
27
-78
-74% -$3.46K ﹤0.01% 1197
2023
Q1 		$3.94K Hold
105
– – ﹤0.01% 1046
2022
Q4 		$2.94K Buy
+105
New +$3.05K ﹤0.01% 1047

Other funds holding AMPH

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return